Business
More than a century in the making, a genomics revolution is now unfolding. The extent of the Covid-19 outbreak has prompted nations and biotech companies to pour billions of dollars and emergency resources into the field, spurring it to new heights of potential. Within a month of the first novel coronavirus case reported in Wuhan, the 29,903 letters that make up the pathogen’s genome were published online.
Now, more than a year later, researchers around the world are scrutinising the genetic markers of the virus, helping public health workers at nearly every layer of pandemic response, from contact tracing to surfacing treatments. Last month, Abu Dhabi strategic investment fund Mubadala announced it would invest $1.1 billion in UK life sciences businesses to boost the sector after the pandemic.
To explain the science and investment opportunity for the flourishing field, host Kelsey Warner is joined by Damien Ng, a research analyst at Swiss wealth management firm Julius Baer.
In this episode:
The life sciences and genomics revolution spurred by Covid-19 (0m 40s)
What is genomics? (2m 16s)
What are the investment opportunities? (5m 10s)
Health data and privacy (15m 50s)
Read more on our website:
Now, more than a year later, researchers around the world are scrutinising the genetic markers of the virus, helping public health workers at nearly every layer of pandemic response, from contact tracing to surfacing treatments. Last month, Abu Dhabi strategic investment fund Mubadala announced it would invest $1.1 billion in UK life sciences businesses to boost the sector after the pandemic.
To explain the science and investment opportunity for the flourishing field, host Kelsey Warner is joined by Damien Ng, a research analyst at Swiss wealth management firm Julius Baer.
In this episode:
The life sciences and genomics revolution spurred by Covid-19 (0m 40s)
What is genomics? (2m 16s)
What are the investment opportunities? (5m 10s)
Health data and privacy (15m 50s)
Read more on our website:
• UAE and UK sign £1bn deal to invest in life sciences
• Coronavirus: why quickly mapping the viral genome was ‘extraordinary’ and what's next
• Coronavirus explained: Why experts say more countries need to search for new Covid-19 mutations
• Omics gene-sequencing lab in Abu Dhabi to revolutionise health care
Subscribe to Business Extra for free to receive new episodes every week
Apple Podcasts | Google Podcasts | Audioboom | Spotify | RSS
Apple Podcasts | Google Podcasts | Audioboom | Spotify | RSS
More Episodes
Why rent prices in Dubai have been falling
2019-05-16
14
2019-05-16
14
Abraaj: a cautionary tale
2019-05-08
72
2019-05-08
72
A hyper week for aviation and travel in Dubai
2019-05-02
17
2019-05-02
17
Huawei and the promise of 5G
2019-04-24
14
2019-04-24
14
'Dr Doom' Nouriel Roubini upbeat on global outlook
2019-04-17
29
2019-04-17
29
What to expect at this year's CityScape Abu Dhabi
2019-04-11
11
2019-04-11
11
StartAD's Ramesh Jagannathan on innovation in the UAE
2019-03-07
23
2019-03-07
23
Brexit uncertainty clouds investors' outlook
2019-02-28
17
2019-02-28
17
How Adnoc earned world's top oil and gas credit rating
2019-02-20
28
2019-02-20
28
Abu Dhabi hosts the world’s military big guns
2019-02-14
20
2019-02-14
20
The curious case of QuadrigaCX
2019-02-05
23
2019-02-05
23
Adnoc and Saudi Arabia take centre stage
2019-01-31
25
2019-01-31
25
Is the worst over for investors?
2019-01-16
11
2019-01-16
11
Is the US economy bound for recession?
2019-01-10
10
2019-01-10
10
Get this podcast on your
phone, FREE
